Catheter-Directed Thrombolysis Devices Market Report 2022-27: Top Companies Growth Overview, Industry Size, Share and Forecast | IMARC Group

The latest research study "Catheter-Directed Thrombolysis Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global catheter-directed thrombolysis devices market reached a value of US$ 338.0 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 467.0 Million by 2027, exhibiting a CAGR of 5.57% during 2022-2027.

Request a Free PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/catheter-directed-thrombolysis-devices-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Industry Overview and Application :

By avoiding organ and tissue damage, thrombolysis is a therapeutic method for treating blood clots and enhancing blood flow. Devices for catheter-directed thrombolysis assist in dissolving or removing blood clots and restoring blood flow. They are used when blood begins to clot and forms a semi-solid gel or clouts and are minimally invasive. A radiography table, one or more x-ray tubes, a catheter, special drugs, a medical gadget to dissolve blood clots, an x-ray camera, and a monitor to view the treatment are among the equipment. During the process, other equipment is also used, including ultrasound machines, heartbeat monitors, and blood pressure monitors.

Catheter-Directed Thrombolysis Device Market Trends and Drivers:

The global catheter-directed thrombolysis devices market is primarily driven by the increasing prevalence of stroke, pulmonary embolism, and deep vein thrombosis among individuals. The rising geriatric population, which is prone to cardiovascular diseases, is also fueling the growth of the market.

In addition to this, increasing health consciousness among individuals is facilitating the early detection and treatment of cardiovascular diseases. Moreover, governing bodies are extensively investing in the healthcare sector to provide high-quality patient care and develop advanced clot management technologies, which, in turn, is propelling the market growth.

Furthermore, the availability of emergency medical services, coupled with favorable health insurance coverage, is expected to significantly impact the market in the upcoming years.

Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=4990&flag=F

Global Catheter-Directed Thrombolysis Devices Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

AngioDynamics, Inc., Boston Scientific Corporation, Inari Medical, Inc., iVascular, S.L.U, Medtronic Plc, Penumbra, Inc., Straub Medical AG (Becton, Dickinson and Company), Teleflex Incorporated, Thrombolex Inc. etc.

The report has segmented the market on the basis of region, delivery mode, indication and end user.

Breakup by Delivery Mode:
• Directly Delivery to Blood Clot
• Positioning Medical Device at Clot Site

Breakup by Indication:
• Pulmonary Embolism (PE)
• Deep Vein Thrombosis (DVT)
• Stroke
• Other

Breakup by End User:
• Hospitals
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/catheter-directed-thrombolysis-devices-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Related Reports:

C-Arms Market Size is Projected to Reach US$ 2,712.0 Million by 2027 | IMARC Group : https://www.einpresswire.com/article/570057450/c-arms-market-size-is-projected-to-reach-us-2-712-0-million-by-2027-imarc-group

Hemoglobinopathies Market Size, Industry Share, Trends, Growth, Scope And Outlook 2022-2027 : https://www.einpresswire.com/article/570201123/hemoglobinopathies-market-size-industry-share-trends-growth-scope-and-outlook-2022-2027

Global Neuroscience Market Size 2022-2027 Trends, Research Report, Analysis, Growth - IMARC Group : https://www.einpresswire.com/article/570202215/global-neuroscience-market-size-2022-2027-trends-research-report-analysis-growth-imarc-group

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.